Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: A randomised controlled trial

The Lancet Oncology

Volumn 16, Issue 9, 2015, Pages 1123-1132

  Moss, Sue M ^a   Wale, Christopher ^a   Smith, Robert ^b   Evans, Andrew ^c   Cuckle, Howard ^d   Duffy, Stephen W ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b AMERICAN CANCER SOCIETY   (United States)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HUMAN; MAMMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; UNITED KINGDOM; BREAST; BREAST NEOPLASMS; EARLY DIAGNOSIS; PATHOLOGY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; UNITED STATES;

ADULT; BREAST; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; UNITED STATES;

EID: 84940576679     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(15)00128-X     Document Type: Article

References (31)

1. Dowling EC, Klabunde C, Patnick J, Ballard-Barbash R Breast and cervical cancer screening programme implementation in 16 countries. J Med Screen 2010, 17:139-146. for the International Cancer Screening Network (ICSN).
2. Nationwide cluster-randomised trial of extending the NHS breast screening age range in England, (accessed April 2, 2015). http://www.isrctn.com/ISRCTN33292440.
3. Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, Straif K Viewpoint of the IARC Working Group. N Engl J Med 2015, 372:2353-2358. for the International Agency for Research on Cancer Handbook Working Group Breast-Cancer Screening.
4. Tabár L, Chen HH, Fagerberg G, Duffy SW, Smith TC Recent results from the Swedish two-county trial: the effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening. J Natl Cancer Inst Monogr 1997, 22:43-47.
5. Hellquist BN, Duffy SW, Abdsaleh S, et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer 2011, 117:714-722.
6. van Schoor G, Moss SM, Otten JD, et al. Effective biennial mammographic screening in women aged 40-49. Eur J Cancer 2010, 46:3137-3140.
7. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2009, 151:716-726. US Preventive Services Task Force.
8. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med 2009, 151:727-737. the US Preventive Services Task Force.
9. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet 2006, 368:2053-2060. the Trial Management Group.
10. Moss S A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. J Med Screen 1999, 6:144-148. the Trial Steering Group.
11. Aalen OO Nonparametric inference for a family of counting processes. Ann Stat 1978, 6:701-726.
12. Baker SG, Kramer BS, Prorok PC Early reporting for cancer screening trials. J Med Screen 2008, 15:122-129.
13. Cuzick J, Edwards R, Segnan N Adjusting for non-compliance and contamination in randomized clinical trials. Stat Med 1997, 16:1017-1029.
14. Johns LE, Moss SM Randomized controlled trial of mammographic screening from age 40 ('Age' trial): patterns of screening attendance. J Med Screen 2010, 17:37-43. the Trial Management Group.
15. Autier P, Boniol M, Gavin A, Vatten LJ Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ 2011, 343:d4411.
16. Autier P, Koechlin A, Smans M, Vatten L, Boniol M Mammography screening and breast cancer mortality in Sweden. J Natl Cancer Inst 2012, 104:1080-1093.
17. Blanks RG, Bennett RL, Patnick J, Cush S, Davison C, Moss SM The effect of changing from one to two views at incident (subsequent) screens in the NHS breast screening programme in England: impact on cancer detection and recall rates. Clin Radiol 2005, 60:674-680.
18. Dibden A, Offman J, Parmar D, et al. Reduction in interval cancer rates following the introduction of two-view mammography in the UK breast screening programme. Br J Cancer 2014, 110:560-564.
19. Evans AJ, Kutt E, Record C, Waller M, Bobrow L, Moss S Radiological and pathological findings of interval cancers in a multi-centre, randomized, controlled trial of mammographic screening in women from age 40-41 years. Clin Radiol 2007, 62:348-352.
20. Møller H, Linklater KM, Robinson D A visual summary of the EUROCARE-4 results: a UK perspective. Br J Cancer 2009, 101(suppl 2):S110-S114.
21. NHS Breast Cancer Screening Programme Public Health England, (accessed April 1, 2015). http://www.cancerscreening.nhs.uk/breastscreen/archived-statistics-bulletins.html.
22. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 2005, 353:1773-1783. the Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group.
23. Perry NM, Patani N, Milner SE, et al. The impact of digital mammography on screening a young cohort of women for breast cancer in an urban specialist breast unit. Eur Radiol 2011, 21:676-682.
24. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 2014, 348:g366.
25. Tarone RE The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study. Cancer 1995, 75:997-1003.
26. Boyd NF, Jong RA, Yaffe MJ, Tritchler D, Lockwood G, Zylak CJ A critical appraisal of the Canadian National Breast Cancer Screening Study. Radiology 1993, 189:661-663.
27. Baines CJ The Canadian National Breast Screening Study: a perspective on criticisms. Ann Intern Med 1994, 120:326-334.
28. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002, 359:909-919.
29. Bjurstam N, Björneld L, Warwick J, et al. The Gothenburg Breast Screening Trial. Cancer 2003, 97:2387-2396.
30. Andersson I, Janzon L Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program. J Natl Cancer Inst Monogr 1997, 22:63-67.
31. Duffy SW, Parmar D Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time. Breast Cancer Res 2013, 15:R41.